Reduced cancer incidence among patients with schizophrenia
Open accessAbstract
BACKGROUND: The incidence of cancer in patients with schizophrenia has been conversely reported to be higher, lower, or similar to that in the general population. The effects of lifestyle factors such as excess smoking, exposure to neuroleptic medications, and genetic factors that may influence the incidence of cancer in this group are not clear. The current study was performed to evaluate the frequency of cancer in a large cohort of patients with schizophrenia and to determine the standardized incidence ratios (SIRs) of any malignancy in this group. METHODS: Data regarding the design, setting, and participants of the current study were analyzed from a cohort of 3226 patients with schizophrenia who were enrolled in the computerized health registry of the Abarbanel Mental Health Center between1993–2003. The mean age of the patients at the time of the diagnosis of cancer was 49 ± 14.7 years, with the majority of patients (61%) being male. All patients with schizophrenia records in the database were combined with the records of the Israeli National Cancer Registry to identify pathologically confirmed cancer comorbidity. The cancer incidence rates among patients with schizophrenia were compared with the expected incidence in an age‐matched and gender‐matched general population sample for the same time interval. RESULTS: Among 1247 female patients with schizophrenia, 22 (1.8%) developed breast cancer and 68 (5.5%) developed cancers of any type. Fifty‐two of the 1979 male schizophrenic patients (2.6%) developed cancer. The SIRs were 0.58 (95% confidence interval [95% CI], 0.48–0.69) with a P value of < 0.05 for all cancers in the cohort, and 0.60 (95% CI, 0.37–0.90) for female breast cancer. CONCLUSIONS: The results of the current study demonstrate a reduced risk of cancer in patients with schizophrenia. The mechanisms responsible for the lower risk need be investigated further. Cancer 2005. © 2005 American Cancer Society.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Some studies have demonstrated a decreased cancer risk in schizophrenia.
“Some studies have demonstrated a decreased cancer risk in schizophrenia (440-448).”
From Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care (2011) · cites this paper as [447]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The 1986 census of population and housing
Cornish, J. K. (1985) · Journal of the Australian Population Association · doi:10.1007/bf03041202 · Cited by 1,417 · see citing works
Causes of the excess mortality of schizophrenia
Brown, S., Inskip, H., & Barraclough, B. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.3.212 · Cited by 1,087 · see citing works
Medical Comorbidity in Schizophrenia
Jeste, D. V., Gladsjo, J. A., Lindamer, L. A., & Lacro, J. P. (1996) · Schizophrenia Bulletin · doi:10.1093/schbul/22.3.413 · Cited by 614 · see citing works
Schizophrenia and smoking: an epidemiological survey in a state hospital
de León, J., Dadvand, M., Canuso, C. M., Odom-White, A., Stanilla, J. K., & Simpson, G. M. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.3.453 · Cited by 417 · see citing works
Incidence of Cancer Among Persons With Schizophrenia and Their Relatives
Lichtermann, D., Ekelund, J., Pukkala, E., Tanskanen, A., & Lönnqvist, J. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.6.573 · Cited by 292 · cited 7× · see citing works
“Conversely, Lichtermann et al.1 reported on a higher overall cancer risk, with nearly half of the excess cases attributable to lung cancer, yet the incidence of breast cancer was unchanged.”
BackgroundResultInfluentialElevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects
Halbreich, U. M., Kinon, B. J., Gilmore, J. A., & Kahn, L. (2002) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00112-9 · Cited by 250 · see citing works
Premature Deaths in Schizophrenia and Affective Disorders
Tsuang, M. T. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780220017001 · Cited by 198 · see citing works
Dickerson, F., McNary, S. W., Brown, C. H., Kreyenbuhl, J. A., Goldberg, R. W., & Dixon, L. B. (2003) · Medical Care · doi:10.1097/01.mlr.0000053440.18761.f0 · Cited by 155 · see citing works
The occurence of cancer in first admitted schizophrenic patients
Mortensen, P. B. (1994) · Schizophrenia Research · doi:10.1016/0920-9964(94)90028-0 · Cited by 142 · see citing works
Mortality and causes of death in schizophrenic patients in Denmark
Mortensen, P. B., & Juel, K. (1990) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1990.tb05466.x · Cited by 138 · see citing works
Investigating the Association Between Cigarette Smoking and Schizophrenia in a Cohort Study
Zammit, S., Allebeck, P., Dalman, C., Lundberg, I., Hemmingsson, T., & Lewis, G. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.12.2216 · Cited by 121 · see citing works
Apoptosis and schizophrenia: is the tumour suppressor gene, p53, a candidate susceptibility gene?
Catts, V. S., & Catts, S. V. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00077-8 · Cited by 118 · see citing works
The association between schizophrenia and cancer: a population-based mortality study
Cohen, M. E., Dembling, B., & Schorling, J. B. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00308-5 · Cited by 114 · see citing works
Cancer incidence of schizophrenic patients. Results of record linkage studies in three countries
Gulbinat, W., Dupont, A., Jablensky, A., Jensen, O. M., Marsella, A., Nakane, Y., & Sartorius, N. (1992) · British Journal of Psychiatry · doi:10.1192/s0007125000297080 · Cited by 110 · see citing works
The possible association between in vitro fertilization treatments and cancer development
Lerner‐Geva, L., Geva, E., Lessing, J. B., Chetrit, A., Modan, B., & amit, A. (2003) · International Journal of Gynecological Cancer · doi:10.1046/j.1525-1438.2003.13041.x · Cited by 100 · see citing works
Are chronic psychiatric patients at increased risk for developing breast cancer?
Halbreich, U. M., Shen, J., & Panaro, V. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.4.559 · Cited by 96 · see citing works
Use of Medical Services by Veterans With Mental Disorders
Druss, B. G., & Rosenheck, R. A. (1997) · Psychosomatics · doi:10.1016/s0033-3182(97)71422-1 · Cited by 93 · see citing works
SAKU, M., TOKUDOME, S., IKEDA, M., KONO, S., MAKIMOTO, K., UCHIMURA, H., MUKAI, A., & YOSHIMURA, T. (1995) · International Journal of Epidemiology · doi:10.1093/ije/24.2.366 · Cited by 84 · cited 1× · see citing works
“The weakness of measuring cancer mortality rather than incidence to index relative risk of cancer is that cancer mortality not only measures cancer incidence but also the survival of those who develop cancer.(6,8) Mortality from other causes may complicate the interpretation.”
BackgroundInformation support to mental health programs : an international perspective
LASKA, E. M., Gulbinat, W. H., & Regier, D. A. (1983) · Medical Entomology and Zoology · Cited by 71 · see citing works
Risk for Cancer in Parents of Patients With Schizophrenia
Dalton, S. O., Laursen, T. M., Mellemkjær, L., Johansen, C., & Mortensen, P. B. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.5.903 · Cited by 69 · see citing works
Schizophrenia and the risk for breast cancer
Dalton, S. O., Laursen, T. M., Mellemkjær, L., Johansen, C., & Mortensen, P. B. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00430-9 · Cited by 61 · see citing works
Barak, Y., Mirecki, I., Knobler, H. Y., Natan, Z., & Aizenberg, D. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1801-2 · Cited by 58 · see citing works
Self-citationDifferences in p53 gene polymorphisms between Korean schizophrenia and lung cancer patients
Park, J. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00155-5 · Cited by 48 · see citing works
Tumor suppressor gene TP53 is genetically associated with schizophrenia in the Chinese population
Yang, Y., Xiao, Z., Chen, W., Sang, H., Guan, Y., Peng, Y., Zhang, D., Gu, Z., Qian, M., He, G., et al. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.07.068 · Cited by 36 · see citing works
Cancer Risk Among Psychiatric Patients: A Hypothesis
Fox, B. H., & Howell, M. A. (1974) · International Journal of Epidemiology · doi:10.1093/ije/3.3.207 · Cited by 29 · see citing works
Flagged first, then by citations
1 of the 26 references couldn’t be matched to a known paper.
Research works printed but not linked: 5
- Dupont A, Jensen OM, Stromgren E, Jablensky A. Incidence of cancer in patients diagnosed as schizophrenic in Den- mark. In: ten Horn GHMM, Giel R, Gulbinat WH, Henderson JH, editors. Psychiatric case registers in public health. Am- sterdam: Elsevier, 1986:229 -239.
- Barak Y, Mirecki I, Knobler HY, Natan Z, Aizenberg D. Sui- cidality and second generation antipsychotics in schizo- phrenia patients: a case-controlled retrospective study dur- ing a 5-year period. Psychopharmacology (Berl). 2004;175: 215-219. Epub 2004 Feb 4.
- Jeste DV, Gladsjo JA, Lindamer LA, Lacro JP. Medical comor- bidity in schizophrenia. Schizophr Bull. 1996;22:413-430.
- Shalev AY, Abaramowitz MZ, Kaplan De-Nour A. Structured clinical interview for axis I DSM-IV patient edition. Jerusa- lem: Hadassah University Hospital, 1994.
- Dalton SO, Munk Laursen T, Mellemkjaer L, Johansen C, Mortensen PB. Schizophrenia and the risk for breast cancer. Schizophr Res. 2003;62:89 -92.
Cited by
Sorted by citations
DE HERT, M., CORRELL, C. U., BOBES, J., CETKOVICH‐BAKMAS, M., COHEN, D., ASAI, I., DETRAUX, J., GAUTAM, S., MÖLLER, H., NDETEI, D. M., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00014.x · Cited by 2,488 · see citing works
Schizophrenia, “just the facts” 4. Clinical features and conceptualization
Tandon, R., Nasrallah, H. A., & Keshavan, M. S. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.03.005 · Cited by 1,031 · see citing works
Physical illness and schizophrenia: a review of the literature
Leucht, S., Burkard, T., Henderson, J., Maj, M., & Sartorius, N. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.01095.x · Cited by 633 · see citing works
Psychosis and autism as diametrical disorders of the social brain
Crespi, B. J., & Badcock, C. R. (2008) · Behavioral and Brain Sciences · doi:10.1017/s0140525x08004214 · Cited by 618 · see citing works
Impact of Stress on Cancer Metastasis
Moreno‐Smith, M., Lutgendorf, S. K., & Sood, A. K. (2010) · Future Oncology · doi:10.2217/fon.10.142 · Cited by 505 · see citing works
Scott, D. S., & Happell, B. (2011) · Issues in Mental Health Nursing · doi:10.3109/01612840.2011.569846 · Cited by 419 · see citing works
Schizophrenia, “Just the Facts”: What we know in 2008
Tandon, R., Keshavan, M. S., & Nasrallah, H. A. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.01.022 · Cited by 412 · see citing works
Inflammation and the two-hit hypothesis of schizophrenia
Feigenson, K. A., Kusnecov, A., & Silverstein, S. M. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.11.006 · Cited by 280 · see citing works
Callaghan, R. C., Veldhuizen, S., Jeysingh, T., Orlan, C., Graham, C., Kakouris, G., Remington, G., & Gatley, J. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.09.014 · Cited by 255 · see citing works
Risk of Malignancy in Patients With Schizophrenia or Bipolar Disorder: Nested Case-Control Study
Hippisley-Cox, J., Vinogradova, Y., Coupland, C., & Parker, C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.12.1368 · Cited by 214 · see citing works
Cancer incidence in patients with schizophrenia and their first‐degree relatives – a meta‐analysis
Catts, V. S., Catts, S. V., O’Toole, B. I., & Frost, A. D. J. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01163.x · Cited by 209 · see citing works
Catalá-López, F., Suárez‐Pinilla, M., Suárez‐Pinilla, P., Valderas, J. M., Gómez-Beneyto, M., Martı́nez, S., Balanzá‐Martínez, V., Climent, J., Valencia, A., McGrath, J. J., et al. (2014) · Psychotherapy and Psychosomatics · doi:10.1159/000356498 · Cited by 201 · see citing works
Capasso, R., Lineberry, T. W., Bostwick, J. M., Decker, P. A., & Sauver, J. L. S. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.10.005 · Cited by 201 · see citing works
Chou, F. H., Tsai, K., Su, C., & Lee, C. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.02.018 · Cited by 147 · see citing works
Tobacco Use Among Individuals With Schizophrenia: What Role Has the Tobacco Industry Played?
Prochaska, J. J., Hall, S. M., & Bero, L. A. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm117 · Cited by 139 · see citing works
A cohort study on mental disorders, stage of cancer at diagnosis and subsequent survival
Chang, C., Hayes, R. D., Broadbent, M. T. M., Hotopf, M. H., Davies, E., Møller, H., & Stewart, R. J. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004295 · Cited by 133 · see citing works
Excess Cancer Mortality in Psychiatric Patients
Kisely, S., Sadek, J., MacKenzie, A., Lawrence, D., & Campbell, L. A. (2008) · The Canadian Journal of Psychiatry · doi:10.1177/070674370805301107 · Cited by 128 · see citing works
Drug Repositioning in Glioblastoma: A Pathway Perspective
Tan, S. K., Jermakowicz, A. M., Mookhtiar, A. K., Nemeroff, C. B., Schürer, S. C., & Ayad, N. G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00218 · Cited by 115 · see citing works
Cancer screening, prevention, and treatment in people with mental illness
Weinstein, L., Stefancic, A., Cunningham, A., Hurley, K., Cabassa, L., & Wender, R. (2015) · Ca · doi:10.3322/caac.21334 · Cited by 93 · see citing works
Disparities in Breast and Cervical Cancer Screening in Women with Mental Illness
Aggarwal, A., Pandurangi, A. K., & Smith, W. R. (2013) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2012.12.006 · Cited by 109 · see citing works
Ranjan, A., Gupta, P., & Srivastava, S. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1233 · Cited by 105 · see citing works
Can Stopping Nerves, Stop Cancer?
Saloman, J. L., Albers, K. M., Rhim, A. D., & Davis, B. M. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.10.002 · Cited by 105 · see citing works
Cancer and the Dopamine D2 Receptor: A Pharmacological Perspective
Weissenrieder, J., Neighbors, J. D., Mailman, R. B., & Hohl, R. J. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.256818 · Cited by 105 · see citing works
Hert, M. A. F. D., Peuskens, J., Sabbe, T., Mitchell, A. J., Stubbs, B., Neven, P., Wildiers, H. P. M. W., & Detraux, J. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12459 · Cited by 98 · see citing works
The incidence rate of cancer in patients with schizophrenia: A meta-analysis of cohort studies
Li, H., Li, J., Yu, X., Zheng, H., Sun, X., Lü, Y., Zhang, Y., Li, C., & Bi, X. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.08.065 · Cited by 96 · see citing works
Association of Schizophrenia With the Risk of Breast Cancer Incidence
Zhuo, C., & Triplett, P. T. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.4748 · Cited by 96 · see citing works
Kisely, S. R., Forsyth, S. J., & Lawrence, D. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415577979 · Cited by 95 · see citing works
Lin, G., Chen, Y.-J., Kuo, D.-J., Jaiteh, L. E. S., Wu, Y., Lo, T.-S., & Li, Y.-H. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr162 · Cited by 90 · see citing works
Repurposing psychiatric drugs as anti-cancer agents
Huang, J., Zhao, D., Liu, Z., & Liu, F. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.058 · Cited by 89 · see citing works
Antipsychotic drugs: Pro-cancer or anti-cancer? A systematic review
Fond, G. B., Macgregor, A., Attal, J., Larue, A., Brittner, M., Ducasse, D., & Capdevielle, D. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.03.026 · Cited by 87 · see citing works
Self-reported motivation to smoke in schizophrenia is related to antipsychotic drug treatment
Barr, A. M., Procyshyn, R. M., Hui, P., Johnson, J. L., & Honer, W. G. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.11.027 · Cited by 85 · see citing works
DNA Damage and Repair in Schizophrenia and Autism: Implications for Cancer Comorbidity and Beyond
Markkanen, E., Meyer, U., & Dianov, G. L. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060856 · Cited by 84 · see citing works
Almeida, O. P., Hankey, G. J., Yeap, B. B., Golledge, J., Norman, P. E., & Flicker, L. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111882 · Cited by 82 · see citing works
Review: Cancer and schizophrenia: is there a paradox?
Hodgson, R. E., Wildgust, H. J., & Bushe, C. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810385489 · Cited by 83 · see citing works
Schizophrenia and breast cancer incidence
Bushe, C., Bradley, A. J., Wildgust, H. J., & Hodgson, R. E. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.07.012 · Cited by 77 · see citing works
Prostate Cancer and Neuroendocrine Differentiation: More Neuronal, Less Endocrine?
Grigore, A. D., Ben‐Jacob, E., & Farach‐Carson, M. C. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00037 · Cited by 76 · see citing works
Penfluridol suppresses pancreatic tumor growth by autophagy-mediated apoptosis
Ranjan, A., & Srivastava, S. (2016) · Scientific Reports · doi:10.1038/srep26165 · Cited by 66 · see citing works
Schizophrenia: The Epidemiological Horizon
Jablensky, A. V., Kirkbride, J. B., & Jones, P. B. (2010) · Wiley eBooks · doi:10.1002/9781444327298.ch10 · Cited by 65 · see citing works
Repurposing antipsychotics as glioblastoma therapeutics: Potentials and challenges
Lee, J., Nam, D., & Lee, J. (2016) · Oncology Letters · doi:10.3892/ol.2016.4074 · Cited by 63 · see citing works
Unmet needs in the management of schizophrenia
Torres‐González, F., Ibáñez-Casas, I., Saldivia, S., Ballester, D., Pamela Grandón, F., Moreno‐Küstner, B., Xavier, M., & Gómez-Beneyto, M. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s41063 · Cited by 60 · see citing works
Cancer risk among parents and siblings of patients with schizophrenia
Levav, I., Lipshitz, I., Novikov, I., Pugachova, I., Kohn, R., Barchana, M., Ponizovsky, A. M., & Werner, H. (2007) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.106.024943 · Cited by 59 · see citing works
Drug rechanneling: A novel paradigm for cancer treatment
Kaushik, I., Ramachandran, S., Prasad, S., & Srivastava, S. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.03.011 · Cited by 58 · see citing works
The origins and evolution of genetic disease risk in modern humans
Crespi, B. J. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05707.x · Cited by 55 · see citing works
Schizophrenia and Cancer: In 2010 Do We Understand the Connection?
Bushe, C., & Hodgson, R. E. (2010) · The Canadian Journal of Psychiatry · doi:10.1177/070674371005501203 · Cited by 55 · see citing works
Crespi, B. J. (2011) · Autism Research · doi:10.1002/aur.208 · Cited by 54 · see citing works
Association between schizophrenia and genetic variation in DCC: a case–control study
Grant, A., Fathalli, F., Rouleau, G., Joober, R., & Flores, C. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.02.023 · Cited by 53 · see citing works
Kodesh, A., Goldshtein, I., Gelkopf, M., Goren, I., Chodick, G., & Shalev, V. (2012) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-012-0478-9 · Cited by 53 · see citing works
Ishikawa, H., Yasunaga, H., Matsui, H., Fushimi, K., & Kawakami, N. (2016) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.114.156265 · Cited by 53 · see citing works
Cancer in patients with schizophrenia: W hat is the next step?
Chou, F. H., Tsai, K., Wu, H., & Shen, S. (2016) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12420 · Cited by 53 · see citing works
Pettersson, D. R., Gissler, M., Hällgren, J., Ösby, U., Westman, J., & Bobo, W. V. (2020) · Epidemiology and Psychiatric Sciences · doi:10.1017/s204579602000044x · Cited by 52 · see citing works
Personalized Treatment of Glioblastoma: Current State and Future Perspective
Rončević, A., Koruga, N., Koruga, A. S., Rončević, R., Rotim, T., Šimundić, T., Kretić, D., Perić, M., Turk, T., & Štimac, D. (2023) · Biomedicines · doi:10.3390/biomedicines11061579 · Cited by 51 · see citing works
Antipsychotic dopamine receptor antagonists, cancer, and cancer stem cells
Roney, M. S. I., & Park, S. (2018) · Archives of Pharmacal Research · doi:10.1007/s12272-018-1017-3 · Cited by 50 · see citing works
Clozapine Induces Autophagic Cell Death in Non-Small Cell Lung Cancer Cells
Yin, Y., Lin, C.-C., Chen, T., Chen, J., Tsai, H., Wang, C.-Y., & Chen, S. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000369751 · Cited by 47 · see citing works
Reduced tumor growth in a mouse model of schizophrenia, lacking the dopamine transporter
Asada, M., Ebihara, S., Numachi, Y., Okazaki, T., Yamanda, S., Ikeda, K., Yasuda, H., Sora, I., & Arai, H. (2008) · International Journal of Cancer · doi:10.1002/ijc.23562 · Cited by 47 · see citing works
Mori, T., Kabashima, K., Fukamachi, S., Kuroda, E., Sakabe, J., Kobayashi, M., Nakajima, S., Nakano, K., Tanaka, Y., Matsushita, S., et al. (2013) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2013.03.008 · Cited by 47 · see citing works
Physical Illness and Schizophrenia
Leucht, S., Burkard, T., Henderson, J., Maj, M., & Sartorius, N. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511543951 · Cited by 45 · see citing works
Haloperidol Induced Cell Cycle Arrest and Apoptosis in Glioblastoma Cells
Papadopoulos, F., Isihou, R., Alexiou, G. Α., Tsalios, T., Vartholomatos, E., Markopoulos, G. S., Sioka, C., Tsekeris, P. G., Kyritsis, A. P., & Galani, V. (2020) · Biomedicines · doi:10.3390/biomedicines8120595 · Cited by 42 · see citing works
Lin, C., Lane, H., Chen, T., Wu, Y., Wu, C., & Wu, V. Y. (2013) · Cancer Science · doi:10.1111/cas.12094 · Cited by 40 · see citing works
Lung cancer incidence in patients with schizophrenia: meta-analysis
Zhuo, C., Zhuang, H., Gao, X., & Triplett, P. T. (2019) · The British Journal of Psychiatry · doi:10.1192/bjp.2019.23 · Cited by 40 · see citing works
Prostate cancer and schizophrenia
Torrey, E. F. (2006) · Urology · doi:10.1016/j.urology.2006.08.1061 · Cited by 40 · see citing works
Kantrowitz, J. T., & Citrome, L. (2011) · CNS Drugs · doi:10.2165/11587630-000000000-00000 · Cited by 39 · see citing works
Zhuo, C., Xun, Z., Hou, W., Ji, F., Lin, X., Tian, H., Zheng, W., Chen, M., Liu, C., Wang, W., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01262 · Cited by 39 · see citing works
Breast cancer in women suffering from serious mental illness
Barak, Y., Levy, T., Achiron, A., & Aizenberg, D. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.03.017 · Cited by 36 · see citing works
Self-citationCancer incidence in people with affective disorder: nationwide cohort study in Taiwan, 1997–2010
Hung, Y., Yang, S.-Y., Huang, M., Lung, F., Lin, S., Chen, K., Kuo, C., & Chen, Y. (2014) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.114.144741 · Cited by 36 · see citing works
Wootten, J. C., Wiener, J. C., Blanchette, P., & Anderson, K. K. (2022) · Cancer Epidemiology · doi:10.1016/j.canep.2022.102233 · Cited by 36 · see citing works
Prospects for repurposing CNS drugs for cancer treatment
Abdelaleem, M., Ezzat, H., Osama, M., Megahed, A. A., Alaa, W., Gaber, A. I., Shafei, A., & Refaat, A. (2019) · Oncology Reviews · doi:10.4081/oncol.2019.411 · Cited by 34 · see citing works
Jackson, T. C., Verrier, J. D., Semple‐Rowland, S. L., Kumar, A., & Foster, T. C. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06984.x · Cited by 34 · see citing works
Stimulating TRPM7 suppresses cancer cell proliferation and metastasis by inhibiting autophagy
Xing, Y., Wei, X., Wang, M., Liu, Y., Sui, Z., Wang, X., Zhang, Y., Fei, Y.-H., Jiang, Y., Chen, L., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.10.043 · Cited by 32 · see citing works
New drugs for brain tumors? Insights from chemical probing of neural stem cells
Diamandis, P., Sacher, A. G., Tyers, M., & Dirks, P. B. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2008.10.034 · Cited by 31 · see citing works
Huang, K.-C., Yang, K.-C., Lin, H., Tsao, T. T.-H., Lee, W., Lee, S., & Kao, C. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-s5-s10 · Cited by 30 · see citing works
Xue, Q., Liu, Z., Feng, Z., Xu, Y. X., Zuo, W., Wang, Q., Gao, T., Zeng, J., Hu, X., Jia, F., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109598 · Cited by 30 · see citing works
Comprehensive functional annotation of susceptibility SNPs prioritized 10 genes for schizophrenia
Niu, H., Yang, P., Chen, H., Hao, R.-H., Dong, S., Yao, S., Chen, X., Yan, H., Zhang, Y., Chen, Y., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0398-5 · Cited by 29 · see citing works
Chen, M., Tsai, S., Su, T., Li, C., Lin, W., Cheng, C., Chen, T., & Bai, Y. (2021) · International Journal of Cancer · doi:10.1002/ijc.33914 · Cited by 29 · see citing works
Rai, S., Tanaka, H., Suzuki, M., Espinoza, J. L., Kumode, T., Tanimura, A., Yokota, T., Oritani, K., Watanabe, T., Kanakura, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17666-8 · Cited by 29 · see citing works
Crosstalk Between Peripheral Innervation and Pancreatic Ductal Adenocarcinoma
Ni, B., Yin, Y., Li, Z., Wang, J., Wang, X., & Wang, K. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01082-1 · Cited by 30 · see citing works
Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma
Rebelo, R., Polónia, B. R. G., Santos, L. L., Vasconcelos, M. H., & Xavier, C. P. R. (2021) · Pharmaceuticals · doi:10.3390/ph14030280 · Cited by 28 · see citing works
Perini, G., Grigoletti, L., Hanife, B., Biggeri, A., Tansella, M., & Amaddeo, F. (2013) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-013-0765-0 · Cited by 26 · see citing works
de Bartolomeis, A., Ciccarelli, M., Simone, G. D., Mazza, B., Barone, A., & Vellucci, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065945 · Cited by 25 · see citing works
Meta-analysis of the Correlation Between Schizophrenia and Breast Cancer
Zhang, X., Zhao, S., Feijiang, Y., Bo, C., Shifeng, Y., & Qihui, C. (2018) · Clinical Breast Cancer · doi:10.1016/j.clbc.2018.10.012 · Cited by 23 · see citing works
Kopylov, A. T., Petrovskiy, D. V., Stepanov, A. A., Rudnev, V. R., Malsagova, K. A., Butkova, T. V., Zakharova, N. V., Kostyuk, G. P., Kulikova, L. I., Enikeev, D. V., et al. (2021) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2021.103890 · Cited by 22 · see citing works
Persico, M., Abbruzzese, C., Matteoni, S., Matarrese, P., Campana, A. M., Villani, V., Pace, A., & Paggi, M. G. (2022) · Cells · doi:10.3390/cells11020263 · Cited by 22 · see citing works
Wang, Y., Wang, L., Li, X., Liu, B., Zhao, Q., Chen, P., Wang, T., Li, T., Ji, J., Yang, F., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-523 · Cited by 22 · see citing works
Jeong, J. Y., Park, H., Yoo, H., Kim, E., Jeon, B., Lee, J. D., Kang, D., Lee, C. J., Paek, S. H., Roh, E. J., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10051046 · Cited by 20 · see citing works
Jacob, J. R., Palanichamy, K., & Chakravarti, A. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06779-3 · Cited by 20 · see citing works
Psychiatric Disorder as a Risk Factor for Cancer
Whitley, E., Batty, G. D., Mulheran, P. A., Galé, C. R., Osborn, D., Tynelius, P., & Rasmussen, F. E. (2012) · Epidemiology · doi:10.1097/ede.0b013e3182547094 · Cited by 20 · see citing works
Cancer in parents of persons with schizophrenia: Is there a genetic protection?
Gal, G., Goral, A., Murad, H., Gross, R., Pugachova, I., Barchana, M., Kohn, R., & Levav, I. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.04.018 · Cited by 21 · see citing works
Murphy, K. A., Daumit, G. L., Bandara, S. N., Stone, E. M., Kennedy‐Hendricks, A., Stuart, E. A., Pollack, C. E., & McGinty, E. E. (2020) · Psychiatric Services · doi:10.1176/appi.ps.201900299 · Cited by 20 · see citing works
Mammography stages of change in middle-aged women with schizophrenia: An exploratory analysis
Lindamer, L. A., Wear, E., & Sadler, G. R. (2006) · BMC Psychiatry · doi:10.1186/1471-244x-6-49 · Cited by 19 · see citing works
The risk for cancer among patients with schizoaffective disorders
Levav, I., Kohn, R., Barchana, M., Lipshitz, I., Pugachova, I., Weizman, A., & Grinshpoon, A. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.06.010 · Cited by 18 · see citing works
Low Dose of Penfluridol Inhibits VEGF-Induced Angiogenesis
Srivastava, S., Zahra, F. T., Gupta, N., Tullar, P., Srivastava, S. K., & Mikelis, C. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030755 · Cited by 18 · see citing works
Antidepressants and Antipsychotic Agents as Repurposable Oncological Drug Candidates
Antoszczak, M., Markowska, A., Markowska, J., & Huczyński, A. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200907141452 · Cited by 18 · see citing works
Preti, A., & Wilson, D. R. (2011) · Psychiatry Investigation · doi:10.4306/pi.2011.8.2.77 · Cited by 18 · see citing works
Risk of Malignancy in Patients With Schizophrenia or Bipolar Disorder
Hippisley‐Cox, J., Vinogradova, Y., Coupland, C. A. C., & Parker, C. (2015) · Cited by 19 · see citing works
Liu, Z., Liu, X., Fan, R., Jia, Y.-P., Zhang, Q., Gao, X.-Q., Wang, Y., Yang, M., Ji, L.-Z., Zhou, Y., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00724-2 · Cited by 17 · see citing works
Xu, L., Qi, X., Zhu, C., & Wan, L. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s188210 · Cited by 17 · see citing works
Jóźwiak-Bębenista, M., Jasińska-Stroschein, M., & Kowalczyk, E. (2018) · Pharmacological Reports · doi:10.1016/j.pharep.2018.05.005 · Cited by 16 · see citing works
Sato, D., Hamada, Y., Narita, M., Mori, T., Tezuka, H., Suda, Y., Tanaka, K., Yoshida, S., Tamura, H., Yamanaka, A., et al. (2022) · Molecular Brain · doi:10.1186/s13041-022-00902-1 · Cited by 15 · see citing works
The Risk and The Course of Cancer Among People with Severe Mental Illness
Grassi, L. G., McFarland, D. C., & Riba, M. (2022) · Clinical Practice and Epidemiology in Mental Health · doi:10.2174/17450179-v17-e211208-2021-ht2-1910-8 · Cited by 14 · see citing works
miRNAs and their role in the correlation between schizophrenia and cancer
Rizos, E. N., Siafakas, N., Skourti, E., Papageorgiou, C., Tsoporis, J. N., Parker, T. H., Christodoulou, D. I., Spandidos, D. A., Katsantoni, E. Z., & Zoumpourlis, V. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5853 · Cited by 14 · see citing works
Pala, E., & Denkçeken, T. (2019) · Journal of Computational Biology · doi:10.1089/cmb.2019.0412 · Cited by 14 · see citing works
- Authors
- Barak, Y., Achiron, A., Mandel, M., Mirecki, I., & Aizenberg, D.
- Affiliations
- Tel Aviv University (IL)
- Corresponding author
- Barak, Yoram
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2005-11-15
- Volume
- 104
- Issue
- 12
- Pages
- 2817-2821
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1535192849
- Cited by
- 159
- References
- 26
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 11 · 2022: 8 · 2021: 9 · 2020: 8 · 2019: 7 · 2018: 10 · 2017: 4 · 2016: 9 · 2015: 8 · 2014: 12 · 2013: 11 · 2012: 7
- FWCI
- 3.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Health Sciences › Medicine › Psychiatry and Mental health › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- schizophrenia, cancer incidence, breast cancer, standardized incidence ratio, cancer comorbidity, antipsychotic drugs, smoking, genetic factors, psychiatric patients
- MeSH terms
- Adult, Aged, Female, Humans, Israel, Male, Middle Aged, Neoplasms, Prognosis, Registries, Schizophrenia, Severity of Illness Index, Cohort Studies, Comorbidity, Incidence, Survival Rate, Confidence Intervals, Odds Ratio, Age Distribution, Sex Distribution, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
